HomeHOSPITALSPhilips to Provide Spanish Viamed Hospital Group with Advanced Diagnostic Imaging Solutions

Philips to Provide Spanish Viamed Hospital Group with Advanced Diagnostic Imaging Solutions

Philips, a global leader in health technology, and Viamed, one of Spain’s leading private hospital groups, today announced that Philips has been selected to install the latest advanced diagnostic imaging solutions in clinical centers throughout Viamed’s network, supporting the group’s healthcare professionals to further improve patient care.

Viamed has a total of 11 hospitals and 15 healthcare centers in the Andalusia, Aragon, Catalonia, La Rioja, Murcia and Madrid regions of Spain.

This agreement with Philips will allow Viamed to continue with the technological renewal of Viamed’s imaging capabilities throughout its network of hospitals. As a starting point, Viamed has already acquired Philips MR and CT scanners for its hospitals in Madrid, Seville (Andalusia) and Huesca (Aragon), as well as a state-of-the-art digital radiology room for its hospital in Tarragona (Catalonia).

“Developing our technology innovation strategy with a partner like Philips allows us to accelerate progress in meeting our objective of maintaining healthcare excellence and placing the patient at the center of all our operations,” said Paulo Gonçalves, CEO of Viamed. “The start of this collaboration has been the acquisition of state-of-the-art equipment through which our professionals will be able to develop their work and provide our patients with the best care.”

“We are very proud of the trust placed in us for renewing and procuring Viamed’s diagnostic imaging solutions,” said Juan Sanabria, General Manager of Philips Ibérica. “It will help Viamed to continue offering the best health outcomes and the best experience for its patients and healthcare professionals.” 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy